Integral Health Asset Management LLC Acquires New Stake in Sanofi (NASDAQ:SNY)

Integral Health Asset Management LLC acquired a new stake in Sanofi (NASDAQ:SNY) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 200,000 shares of the company’s stock, valued at approximately $9,704,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. UBS Group AG increased its holdings in Sanofi by 5.1% during the 4th quarter. UBS Group AG now owns 934,635 shares of the company’s stock worth $46,479,000 after purchasing an additional 45,175 shares during the period. Corient Private Wealth LLC increased its holdings in Sanofi by 62.1% during the 4th quarter. Corient Private Wealth LLC now owns 169,494 shares of the company’s stock worth $8,429,000 after purchasing an additional 64,949 shares during the period. Congress Wealth Management LLC DE purchased a new stake in Sanofi during the 4th quarter worth about $226,000. Johnson Financial Group Inc. purchased a new stake in Sanofi during the 4th quarter worth about $31,000. Finally, Catalytic Wealth RIA LLC purchased a new stake in Sanofi during the 4th quarter worth about $346,000. Hedge funds and other institutional investors own 10.04% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on SNY shares. StockNews.com upgraded Sanofi from a “buy” rating to a “strong-buy” rating in a report on Friday. Argus increased their price objective on Sanofi from $55.00 to $60.00 and gave the company a “buy” rating in a report on Friday, July 26th. Finally, Citigroup upgraded Sanofi to a “strong-buy” rating in a report on Tuesday, September 17th. Three investment analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $57.50.

Sanofi Stock Down 1.1 %

Shares of NASDAQ SNY opened at $57.63 on Monday. The stock has a market cap of $145.96 billion, a PE ratio of 28.96, a price-to-earnings-growth ratio of 1.62 and a beta of 0.60. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. Sanofi has a 52-week low of $42.63 and a 52-week high of $58.97. The business has a 50-day moving average price of $54.34 and a 200 day moving average price of $50.50.

Sanofi (NASDAQ:SNY) last announced its earnings results on Thursday, July 25th. The company reported $0.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.88 by $0.05. The firm had revenue of $10.75 billion during the quarter, compared to analysts’ expectations of $16.86 billion. Sanofi had a return on equity of 26.29% and a net margin of 9.60%. The business’s revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.95 EPS. Equities research analysts forecast that Sanofi will post 4.25 earnings per share for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.